• Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

  • Feb 22 2023
  • Duración: 13 m
  • Podcast

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2  Por  arte de portada

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

  • Resumen

  • Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

    In this video, Dr. Tara discusses:
    - (0:34) Impacts of Ferring's FDA approval on Microba
    - (5:30) Drivers behind Microba's increase in revenue
    - (7:12) What 2023 looks like for Monash IVF
    - (8:39) Monash IVF's rating
    - (11:45) Monash IVF's impact from legal action

    Note: This interview was filmed on 7 February 2023.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.